Sartorius will expand its capacities for production, innovation, and storage at its French facilities in Aubagne, Cergy and Lourdes in order to meet the strong demand of the biopharmaceutical industry
The Global Pathogen Center for Pathogen Research and Human Health to broaden understanding of emerging pathogens – ranging from Zika virus to SARS-CoV-2 (which causes COVID-19) – and to expedite critically needed treatments and vaccines.
Vaxess Technologies celebrates the grand opening of their 3,600 square feet pilot GMP manufacturing facility on Monday.
VetStem Biopharma, a veterinary and human regenerative medicine CRO, used its extensive experience, FDA master files, and database of veterinary stem cell therapy to secure FDA approval of a human IND for stem cell therapy in patients with osteoarthritis. VetStem made the application to FDA on behalf of its subsidiary, Personalized Stem Cells, Inc.
Mile High Labs, a Colorado startup that calls itself the world’s largest manufacturer of products, purchased the plant in Broomfield, Colorado, for about $18.8 million.
Multinational pharmaceutical company GlaxoSmithKlyne (GSK) launched two new pharmaceutical manufacturing facilities and an expanded production building at its Jurong site. According to GSK, the new and expanded sites will allow the faster production of drugs and Active Pharmaceutical Ingredients (APIs) for clinical trials.
In one of the first-of-its-kind studies, Cleveland Clinic researchers found that the use of electronic inhaler monitoring, in combination with a disease management program, is associated with reduced healthcare utilization in patients with chronic obstructive pulmonary disease (COPD).
Thermo Fisher Scientific Inc., the world leader in serving science, today announced that it is investing more than $50 million in its global bioproduction capabilities to provide additional capacity for manufacturing single-use bioprocess container (BPC) systems.
More than 500 invited guests and customers of Romaco China and Truking recently attended the official opening of the new “Romaco China Solids Process Centre”. This high-tech laboratory on the Truking campus in Changsha is equipped with Innojet and Kilian machines.
Precigen commenced the build-out of the nearly 5,000 square foot manufacturing facility in 2018 to support gene therapy manufacturing. The good manufacturing practices (GMP) facility was designed with agility and control in mind, focusing on rapid manufacturing and the ability to scale production appropriately to meet early stage clinical trial needs.
Stem Cell Medicine Ltd. (SCM), a biotechnology company developing new therapies for neurological indications and rare diseases through gene therapy, cell therapy, exosomes, novel molecules and combinations with existing pharmaceuticals, announced today that it has received funding from the Israeli Ministry of the Economy to build a gene therapy facility.
ThermoGenesis Corp, a private corporation owned by Cesca Therapeutics, and a market leader in automated cellular processing and autologous cell therapies for regenerative medicine, today announced the construction and qualification of a new Class